Pegavision Corporation (TPE:6491)
Taiwan
· Delayed Price · Currency is TWD 360.00
-1.50 (-0.42%)
Apr 2, 2025, 10:40 AM CST
Pegavision Revenue
In the year 2024, Pegavision had annual revenue of 6.82B TWD with 0.40% growth. Pegavision had revenue of 1.79B in the quarter ending December 31, 2024, a decrease of -11.92%.
Revenue
6.82B
Revenue Growth
+0.40%
P/S Ratio
4.12
Revenue / Employee
n/a
Employees
n/a
Market Cap
28.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.82B | 27.44M | 0.40% |
| Dec 31, 2023 | 6.79B | 468.66M | 7.41% |
| Dec 31, 2022 | 6.32B | 726.16M | 12.98% |
| Dec 31, 2021 | 5.60B | 1.62B | 40.64% |
| Dec 31, 2020 | 3.98B | 623.28M | 18.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Center Laboratories | 1.62B |
| Polaris Group | 107.00M |